ID28909A - Antagonis reseptor serotonin terenkapsulasi polimer yang dapat terurai hayati dan metode pembuatannya - Google Patents

Antagonis reseptor serotonin terenkapsulasi polimer yang dapat terurai hayati dan metode pembuatannya

Info

Publication number
ID28909A
ID28909A IDW00200101296A ID20011296A ID28909A ID 28909 A ID28909 A ID 28909A ID W00200101296 A IDW00200101296 A ID W00200101296A ID 20011296 A ID20011296 A ID 20011296A ID 28909 A ID28909 A ID 28909A
Authority
ID
Indonesia
Prior art keywords
seragonin
biological
decrease
polymer
production method
Prior art date
Application number
IDW00200101296A
Other languages
English (en)
Indonesian (id)
Inventor
Rachel S Kohn
Sthephen J Hanley
Stephen J Comiskey
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of ID28909A publication Critical patent/ID28909A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
IDW00200101296A 1998-12-16 1999-11-22 Antagonis reseptor serotonin terenkapsulasi polimer yang dapat terurai hayati dan metode pembuatannya ID28909A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21298698A 1998-12-16 1998-12-16

Publications (1)

Publication Number Publication Date
ID28909A true ID28909A (id) 2001-07-12

Family

ID=22793267

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101296A ID28909A (id) 1998-12-16 1999-11-22 Antagonis reseptor serotonin terenkapsulasi polimer yang dapat terurai hayati dan metode pembuatannya

Country Status (35)

Country Link
EP (1) EP1140026B1 (sr)
JP (1) JP4759141B2 (sr)
KR (1) KR100707710B1 (sr)
CN (1) CN1195497C (sr)
AP (1) AP1769A (sr)
AR (1) AR021652A1 (sr)
AT (1) ATE303795T1 (sr)
AU (1) AU770673B2 (sr)
BG (1) BG65500B1 (sr)
BR (1) BR9916276A (sr)
CA (1) CA2355077C (sr)
CR (1) CR6424A (sr)
CZ (1) CZ301947B6 (sr)
DE (1) DE69927177T2 (sr)
DK (1) DK1140026T3 (sr)
EA (1) EA004502B1 (sr)
EE (1) EE200100314A (sr)
ES (1) ES2245128T3 (sr)
HK (1) HK1041645B (sr)
HR (1) HRP20010446A2 (sr)
HU (1) HU226586B1 (sr)
ID (1) ID28909A (sr)
IL (2) IL143761A0 (sr)
ME (2) MEP19408A (sr)
NO (1) NO20012981L (sr)
NZ (1) NZ511962A (sr)
OA (1) OA11728A (sr)
PL (1) PL196822B1 (sr)
RS (1) RS50123B (sr)
SK (1) SK285812B6 (sr)
TR (1) TR200101759T2 (sr)
TW (1) TWI221418B (sr)
UA (1) UA73101C2 (sr)
WO (1) WO2000035423A1 (sr)
ZA (1) ZA200104899B (sr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10061932A1 (de) * 2000-12-13 2002-10-24 Pharmatech Gmbh Wirkstoffhaltige Mikropartikel und Verfahren zur Herstellung der Mikropartikel durch Abrasion
WO2002075273A2 (en) * 2001-03-20 2002-09-26 Euroscreen S.A. Screening, diagnostic and/or dosage method and device of an agonist and/or antagonist for a calcium-coupled receptor
PT1392248E (pt) 2001-05-23 2007-10-11 Hexal Ag Processo para a preparação de implantes por meio da preparação de um homogeneizado sem solvente
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
US8691277B2 (en) * 2004-09-21 2014-04-08 Shandong Luye Pharmaceutical Co., Ltd. Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof
US8372432B2 (en) 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
WO2009114648A1 (en) 2008-03-11 2009-09-17 Depomed Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
CN102159193B (zh) * 2008-09-18 2015-09-16 普渡制药公司 包含聚(ε-己内酯)的药物剂型
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
WO2010151746A2 (en) * 2009-06-26 2010-12-29 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
US9050335B1 (en) 2011-05-17 2015-06-09 Mallinckrodt Llc Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
US20160193151A1 (en) * 2015-01-06 2016-07-07 Maria Del Pilar Noriega Escobar Dosage form incorporating an amorphous drug solid solution
CN114901064B (zh) * 2019-12-31 2024-03-08 万卡坦卡有限公司 延长释放塑料配方

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389330A (en) * 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
CH679207A5 (sr) * 1989-07-28 1992-01-15 Debiopharm Sa
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
ES2185615T3 (es) * 1990-05-16 2003-05-01 Southern Res Inst Uso y liberacion controlada de las microcapsulas para estimular el crecimiento de la fibra nerviosa.
WO1991018602A1 (en) * 1990-06-01 1991-12-12 Merrell Dow Pharmaceuticals Inc. (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
GB9016885D0 (en) * 1990-08-01 1990-09-12 Scras Sustained release pharmaceutical compositions
ES2111065T5 (es) * 1991-04-16 2005-06-16 Nippon Shinyaku Company, Limited Procedimiento para producir una dispersion solida.
US5505963A (en) * 1993-04-07 1996-04-09 Schwartz Pharma Ag Slow release pharmaceutical preparation
US5456917A (en) * 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
AU4467396A (en) * 1994-12-12 1996-07-10 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm

Also Published As

Publication number Publication date
WO2000035423A1 (en) 2000-06-22
CZ301947B6 (cs) 2010-08-11
NO20012981D0 (no) 2001-06-15
BR9916276A (pt) 2001-09-04
CA2355077C (en) 2009-05-26
KR20010082359A (ko) 2001-08-29
EA004502B1 (ru) 2004-04-29
TWI221418B (en) 2004-10-01
IL143761A (en) 2006-08-01
AU1742500A (en) 2000-07-03
WO2000035423A9 (en) 2002-08-22
HK1041645B (zh) 2005-07-29
CZ20012157A3 (cs) 2001-09-12
JP2002532408A (ja) 2002-10-02
PL348233A1 (en) 2002-05-20
AU770673B2 (en) 2004-02-26
DK1140026T3 (da) 2006-01-02
HK1041645A1 (en) 2002-07-19
HUP0105048A2 (hu) 2002-05-29
NZ511962A (en) 2003-06-30
EE200100314A (et) 2002-08-15
EP1140026B1 (en) 2005-09-07
YU41401A (sh) 2003-12-31
OA11728A (en) 2005-02-01
BG65500B1 (bg) 2008-10-31
SK8282001A3 (en) 2001-11-06
MEP19408A (en) 2010-06-10
DE69927177T2 (de) 2006-06-08
CN1330536A (zh) 2002-01-09
EA200100551A1 (ru) 2001-10-22
SK285812B6 (sk) 2007-08-02
ES2245128T3 (es) 2005-12-16
PL196822B1 (pl) 2008-02-29
CA2355077A1 (en) 2000-06-22
CR6424A (es) 2004-02-26
HU226586B1 (en) 2009-04-28
NO20012981L (no) 2001-07-27
ATE303795T1 (de) 2005-09-15
ZA200104899B (en) 2002-09-16
BG105591A (en) 2002-01-31
DE69927177D1 (de) 2005-10-13
HRP20010446A2 (en) 2002-06-30
AR021652A1 (es) 2002-07-31
TR200101759T2 (tr) 2001-12-21
KR100707710B1 (ko) 2007-04-18
AP1769A (en) 2007-08-22
JP4759141B2 (ja) 2011-08-31
HUP0105048A3 (en) 2002-09-30
RS50123B (sr) 2009-03-25
IL143761A0 (en) 2002-04-21
ME00066B (me) 2010-06-10
EP1140026A1 (en) 2001-10-10
AP2001002198A0 (en) 2001-09-30
CN1195497C (zh) 2005-04-06
UA73101C2 (en) 2005-06-15

Similar Documents

Publication Publication Date Title
ID26099A (id) Turunan amida dan antagonis nosiseptin
DE69913243D1 (de) Verfahren zur Herstellung von Polymeren von konjugierten Dienen
AU2003300074A8 (en) Porous spun polymeric structures and method of making same
DE69839716D1 (de) Leitende Polymere verwendender Festelektrolytkondensator und dessen Herstellungsverfahren
EE200000778A (et) 4-bensüülpiperidiinalküülsulfoksiidi heterotsüklid ja nende kasutamine NMDA retseptori alaliikide suhtes selektiivsete antagonistidena
DE69904145D1 (de) Isolationsanordnung mit flansch und dessen herstellungsmethode
DE60219139D1 (de) Vorrichtung und verfahren zur bildung von luftgelegten faserbahnen mit verbesserter gewichtseigenschaft
ID27093A (id) Lembaran komposit dan metode pembuatannya
DE60202623D1 (de) Verfahren zur herstellung von imprägnierten elektrischen stromleitenden fasern und faserteilchen
DE60314865D1 (de) Verfahren zur herstellung von modifiziertem polymer, danach erhaltenes modifiziertes polymer und kautschukzusammensetzung
ID26074A (id) Monofilamen dan proses produksinya
ID19253A (id) Bahan antagonis reseptor vitronektin, pembuatannya dan penggunaannya
ATE295170T1 (de) Verwendung von einem antagonist der zentralen kannabinoidrezeptoren zur herstellung von arzneimitteln
ID25469A (id) Komposisi sefalosporin amorf yang stabil secara kristalografi dan proses pembuatannya
ID19245A (id) Antagonis reseptor vitronektin, pembuatannya dan pemakaiannya
DE69708848D1 (de) Mischung von erdalkalialkylarylsulfonaten, ihre verwendung als schmierölzusatz und herstellungsmethode
ID27544A (id) Agonis dan antagonis muskarinat
ID24714A (id) Turunan tiazolidindion tersubstitusi, proses pembuatannya dan penggunaan bahan farmasinya
ID30399A (id) Peralatan dan proses untuk pendegasan bahan-bahan plastik, khususnya larutan polikarbonat molekul-tinggi
ID16274A (id) Antagonis bradikinin heterosiklik pengganti-fluoroalkil dan fluoroalkoksi, proses pembuatan dan pemakaiannya
ID28025A (id) Metode pembuatan aminonitril dan diamina
ATE303795T1 (de) In biologisch abbaubare polymere eingekapselter serotoninrezeptor-antagonist und deren herstellungsverfahren
DK0905350T3 (da) Fremgangsmåde til at transportere hydrater i suspension i produktionsströmme
ID23304A (id) Turunan-turunan diaza-spiro [3,5] nonana, proses pembuatan dan penggunaannya
ID22082A (id) Produksi polisulfida-polisulfida organik yang distabilkan dan dihilangkan baunya